Point72 Asset Management
AEGR

Point72 Asset Management’s Aegerion Pharmaceuticals AEGR Stock Holding History

Point72 Asset Management’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,854,600
Closed -$38.8M – 903
2014
Q4 		$38.8M Buy
1,854,600
+1,097,100
+145% +$27.6M 0.3% 119
2014
Q3 		$25.3M Sell
757,500
-166,200
-18% -$5.16M 0.22% 149
2014
Q2 		$29.6M Buy
+923,700
New +$34.4M 0.22% 148

Other funds holding AEGR

SCM
Scopia Capital Management New York $144M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $403M AUM 100.56% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return